US Stock Market Move | Recently, Aptorum Group Limited Class A (APM.US) surged by 50%, with the company's stock price continuously rising.

Following a nearly 107% surge in stock prices on Tuesday, Aptorum Group Limited Class A (APM.US) soared 50% on Thursday, closing at $4.20. Aptorum Group Limited Class A is a preclinical-stage pharmaceutical company that is seeking therapeutic projects in the fields of neurology, infectious diseases, gastroenterology, oncology, and other areas, with exclusive licensing of 11 patented technologies in related fields. Promising projects under the company's ALS-4, SACT-1, and RPIDD are anticipated, but market challenges still persist.